Assessment of biomarker stability and assay performance parameters for medical diagnosis: a case study of diagnosis of major depressive disorder

Publication date

2024

Authors

Jentsch, Mike
der Strate, Barry van
Meddens, Marjolein B M
Meddens, Marcus
Schoevers, Robert

Editors

Advisors

Supervisors

Document Type

Article

Collections

Open Access logo

License

cc_by_nc_nd

Abstract

Aim: Assessing the stability profiles and assay performance of 24 biomarker assays in 32 biomarker/body fluid combinations identified as relevant for prediction of major depressive disorder. Materials & methods: Combinations were tested for stability and assay performance with ELISA at different storage and freeze–thaw conditions in pooled samples of 40 patients. Results: Stability and assay performance issues were found in almost all cases except three biomarkers in urine and three in serum. Conclusion: This study shows that, to produce reliable measurement data, assessments of stability and assay performance are essential. In development, other quality assurance parameters might be implemented to increase the level of measurement reliability by increasing assay performance control.

Keywords

biomarkers, ELISA, major depressive disorder, method development, quality assurance, stability, Drug Discovery, Clinical Biochemistry, Biochemistry, medical

Citation

Jentsch, M, der Strate, B V, Meddens, M, Meddens, M & Schoevers, R 2024, 'Assessment of biomarker stability and assay performance parameters for medical diagnosis : a case study of diagnosis of major depressive disorder', Biomarkers in medicine, vol. 18, no. 2, pp. 59-68. https://doi.org/10.2217/bmm-2023-0416